documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
42 rows where docket_id = "FDA-2009-N-0247" sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: subtype, posted_date, posted_month, comment_start_date, comment_end_date, last_modified, withdrawn, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
document_type 3
- Other 28
- Notice 10
- Supporting & Related Material 4
agency_id 1
- FDA 42
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2009-N-0247-0310 | FDA | None FDA-2009-N-0247 | Food and Drug Administration Transparency Initiative: Increasing Public Access to the Food and Drug Administration’s Compliance and Enforcement Data; Availability | Notice | General Notice | 2014-04-23T04:00:00Z | 2014 | 4 | 2014-04-23T04:00:00Z | 2014-04-23T15:45:21Z | 2014-09188 | 0 | 0 | 09000064816c39bd | |
| FDA-2009-N-0247-0301 | FDA | None FDA-2009-N-0247 | Transparency Initiative: Exploratory Program to Increase Access to Compliance and Enforcement Data | Notice | General Notice | 2012-02-01T05:00:00Z | 2012 | 2 | 2012-02-01T05:00:00Z | 2012-02-01T14:35:20Z | 2012-02184 | 0 | 0 | 0900006480fab1d4 | |
| FDA-2009-N-0247-0302 | FDA | None FDA-2009-N-0247 | FDA Transparency Initiative: Exploratory Program to Increase Access to the Agency’s Compliance and Enforcement Data - Report | Supporting & Related Material | Report | 2012-02-01T05:00:00Z | 2012 | 2 | 2012-02-01T16:11:31Z | 0 | 0 | 0900006480faae1a | |||
| FDA-2009-N-0247-0300 | FDA | None FDA-2009-N-0247 | Report on Good Guidance Practices Improving Efficiency and Transparency; Availability | Notice | Availability of Document | 2011-12-30T05:00:00Z | 2011 | 12 | 2011-12-30T05:00:00Z | 2012-02-29T04:59:59Z | 2011-12-30T14:36:05Z | 2011-33573 | 0 | 0 | 0900006480f8b7c2 |
| FDA-2009-N-0247-0282 | FDA | None FDA-2009-N-0247 | Food and Drug Administration Transparency Initiative: Draft Proposals for Public Comment to Increase Transparency By Promoting Greater Access to the Agency’s Compliance and Enforcement Data - Report | Other | Report | 2011-10-04T04:00:00Z | 2011 | 10 | 2011-10-04T04:00:00Z | 2011-12-03T04:59:59Z | 2012-09-24T13:51:34Z | 0 | 0 | 0900006480f4b7a6 | |
| FDA-2009-N-0247-0281 | FDA | None FDA-2009-N-0247 | Food and Drug Administration Transparency Initiative: Draft Proposals for Public Comment to Increase Transparency By Promoting Greater Access to the Agency’s Compliance and Enforcement Data; Availability | Notice | Notice of Availability | 2011-10-04T04:00:00Z | 2011 | 10 | 2011-10-04T04:00:00Z | 2011-12-03T04:59:59Z | 2011-10-04T14:23:45Z | 2011-25354 | 0 | 0 | 0900006480f4b687 |
| FDA-2009-N-0247-0278 | FDA | None FDA-2009-N-0247 | BioMarin Pharmaceutical Inc. - Request for Appearance | Other | Appearance Request | 2011-07-08T04:00:00Z | 2011 | 7 | 2011-07-08T04:00:00Z | 2013-07-27T22:56:23Z | 0 | 0 | 0900006480a3be58 | ||
| FDA-2009-N-0247-0277 | FDA | None FDA-2009-N-0247 | Nielsen Hobbs - Request for Appearance | Other | Appearance Request | 2011-07-08T04:00:00Z | 2011 | 7 | 2011-07-08T04:00:00Z | 2013-08-11T03:04:32Z | 0 | 0 | 0900006480a3bdd5 | ||
| FDA-2009-N-0247-0276 | FDA | None FDA-2009-N-0247 | BioMarin Pharmaceutical Inc. - Request for Appearance | Other | Appearance Request | 2011-07-08T04:00:00Z | 2011 | 7 | 2011-07-08T04:00:00Z | 2013-08-11T04:35:53Z | 0 | 0 | 0900006480a3bdae | ||
| FDA-2009-N-0247-0260 | FDA | None FDA-2009-N-0247 | FDA Transparency Initiative: Improving Transparency to Regulated Industry | Notice | N-Notice | 2011-01-07T05:00:00Z | 2011 | 1 | 2011-01-07T05:00:00Z | 2011-03-09T04:59:59Z | 2011-03-03T20:47:30Z | 2011-71 | 0 | 0 | 0900006480bc6d30 |
| FDA-2009-N-0247-0261 | FDA | None FDA-2009-N-0247 | Phase III Report_Final, January 2011 - [FDA Transparency Initiative: Improving Transparency to Regulated Industry] - Report | Other | RPT-Report | 2011-01-07T05:00:00Z | 2011 | 1 | 2011-01-07T05:00:00Z | 2011-01-07T15:34:54Z | 0 | 0 | 0900006480bc65f2 | ||
| FDA-2009-N-0247-0256 | FDA | None FDA-2009-N-0247 | Blue Cross Blue Shield Association (BCBSA) re FDA-2009-N-0247-0222 | Supporting & Related Material | Reference (external attachments) | 2010-07-28T04:00:00Z | 2010 | 7 | 2011-09-20T15:52:34Z | 0 | 0 | 0900006480b214bb | |||
| FDA-2009-N-0247-0218 | FDA | None FDA-2009-N-0247 | FDA Transparency Initiative: Draft Proposals for Public Comment Regarding Disclosure Policies of the U.S. Food and Drug Administration; Availability | Notice | N-Notice | 2010-05-21T04:00:00Z | 2010 | 5 | 2010-05-21T04:00:00Z | 2010-07-21T03:59:59Z | 2010-07-22T21:49:25Z | 2010-12314 | 0 | 0 | 0900006480af19ad |
| FDA-2009-N-0247-0184 | FDA | None FDA-2009-N-0247 | Food and Drug Administration Transparency Task Force; Request for Comments | Notice | N-Notice | 2010-03-12T05:00:00Z | 2010 | 3 | 2010-03-12T05:00:00Z | 2010-04-13T03:59:59Z | 2010-04-13T22:14:36Z | 2010-05377 | 0 | 0 | 0900006480abc274 |
| FDA-2009-N-0247-0183 | FDA | None FDA-2009-N-0247 | Summary of Listening Sessions with Industry - Reference | Other | REF-Reference Material (internal attachments) | 2010-03-11T05:00:00Z | 2010 | 3 | 2010-03-11T05:00:00Z | 2013-08-11T04:38:30Z | 0 | 0 | 0900006480abb6c5 | ||
| FDA-2009-N-0247-0178 | FDA | None FDA-2009-N-0247 | Freya Koss - "FDA Public Meeting on Transparency, Nov. 3, 2009" - Testimony | Other | TS-Testimony | 2009-11-16T05:00:00Z | 2009 | 11 | 2009-11-16T05:00:00Z | 2013-07-27T22:59:55Z | 0 | 0 | 0900006480a58bc6 | ||
| FDA-2009-N-0247-0158 | FDA | None FDA-2009-N-0247 | Final Versions - Three Hypothetical Case Studies, Presentation Date November 3, 2009 (Food and Drug Administration Transparency Task Force; Public Meeting;Request for Comments) - Reference | Supporting & Related Material | Reference (internal unless indicated) | 2009-11-13T05:00:00Z | 2009 | 11 | 2011-09-20T15:44:22Z | 0 | 0 | 0900006480a51ccd | |||
| FDA-2009-N-0247-0136 | FDA | None FDA-2009-N-0247 | Food and Drug Administration Transparency Task Force; Public Meeting; Request for Comments | Notice | NM-Notice of Meeting | 2009-10-05T04:00:00Z | 2009 | 10 | 2009-10-05T04:00:00Z | 2009-11-07T04:59:59Z | 2010-04-13T22:17:20Z | E9-23916 | 0 | 0 | 0900006480a3ba54 |
| FDA-2009-N-0247-0128 | FDA | None FDA-2009-N-0247 | Food and Drug Administration Transparency Task Force; Reopening Comment Period | Notice | NEC-Notice of Extension | 2009-08-18T04:00:00Z | 2009 | 8 | 2009-08-18T04:00:00Z | 2009-11-07T04:59:59Z | 2010-04-13T22:15:59Z | E9-19778 | 0 | 0 | 0900006480a0c1f1 |
| FDA-2009-N-0247-0124 | FDA | None FDA-2009-N-0247 | American Association for Health Freedom (AAHF) to the Division of Dockets Management - [Multiple Submitters=801] - Letter | Other | LET-Letter | 2009-08-14T04:00:00Z | 2009 | 8 | 2009-08-14T04:00:00Z | 2013-07-27T22:51:18Z | 0 | 0 | 0900006480a0367a | ||
| FDA-2009-N-0247-0079 | FDA | None FDA-2009-N-0247 | Natural Products Association (NPA) - "Comments for FDA Transparency Meeting (D.Fabricant)" - [Public Meeting FDA Transparency Task Force, June 24, 2009] - Testimony | Other | TS-Testimony | 2009-07-14T04:00:00Z | 2009 | 7 | 2009-07-14T04:00:00Z | 2013-07-27T22:48:11Z | 0 | 0 | 09000064809e5b1c | ||
| FDA-2009-N-0247-0078 | FDA | None FDA-2009-N-0247 | American Epilepsy Society (Dr. S.Schachter) - [Public Meeting FDA Transparency Task Force, June 24, 2009] - Testimony | Other | TS-Testimony | 2009-07-10T04:00:00Z | 2009 | 7 | 2009-07-10T04:00:00Z | 2013-08-11T03:03:04Z | 0 | 0 | 09000064809ed97b | ||
| FDA-2009-N-0247-0070 | FDA | None FDA-2009-N-0247 | Public Meeting FDA Transparency Task Force, June 24, 2009 - Transcript | Other | TR-Transcript | 2009-07-01T04:00:00Z | 2009 | 7 | 2009-07-01T04:00:00Z | 2013-08-11T01:28:16Z | 0 | 0 | 09000064809e7abb | ||
| FDA-2009-N-0247-0066 | FDA | None FDA-2009-N-0247 | Medical Device Safety Institute - "FDA Transparency:Suggestions for Improving Public Health (W.Maisel)" - [Public Meeting FDA Transparency Task Force, June 24, 2009] - Testimony | Other | TS-Testimony | 2009-07-01T04:00:00Z | 2009 | 7 | 2009-06-03T04:00:00Z | 2009-06-04T03:59:59Z | 2013-08-11T04:34:05Z | 0 | 0 | 09000064809e5699 | |
| FDA-2009-N-0247-0071 | FDA | None FDA-2009-N-0247 | Milford Medical Laboratory (S.Lee) - [Public Meeting FDA Transparency Task Force, June 24, 2009] - Testimony | Other | TS-Testimony | 2009-07-01T04:00:00Z | 2009 | 7 | 2009-07-01T04:00:00Z | 2013-07-27T22:48:10Z | 0 | 0 | 09000064809e5666 | ||
| FDA-2009-N-0247-0054 | FDA | None FDA-2009-N-0247 | Breast Cancer Fund - "Testimony for the FDA Transparency Task Force (E.Napalo)" - [Public Meeting FDA Transparency Task Force, June 24, 2009] - Testimony | Other | TS-Testimony | 2009-07-01T04:00:00Z | 2009 | 7 | 2009-07-01T04:00:00Z | 2013-07-27T22:48:10Z | 0 | 0 | 09000064809e563c | ||
| FDA-2009-N-0247-0053 | FDA | None FDA-2009-N-0247 | IDSN (International Document Solutions Network) - "Technology Improves Food Safety Communication (B.Kelser)" - [Public Meeting FDA Transparency Task Force, June 24, 2009] - Testimony | Other | TS-Testimony | 2009-07-01T04:00:00Z | 2009 | 7 | 2009-06-03T04:00:00Z | 2009-06-04T03:59:59Z | 2013-08-11T04:34:05Z | 0 | 0 | 09000064809e5639 | |
| FDA-2009-N-0247-0061 | FDA | None FDA-2009-N-0247 | Bray Patrick-Lake - "Enhancing Transparency via Patient Advocacy in FDA Regulated Clinical Research Trials" [Public Meeting FDA Transparency Task Force, June 24, 2009] - Testimony | Other | TS-Testimony | 2009-07-01T04:00:00Z | 2009 | 7 | 2009-07-01T04:00:00Z | 2013-07-27T22:48:11Z | 0 | 0 | 09000064809e5b15 | ||
| FDA-2009-N-0247-0068 | FDA | None FDA-2009-N-0247 | David Lim, Ph.D. RAC - "Transparencey 101"- [Public Meeting FDA Transparency Task Force, June 24, 2009] - Testimony | Other | TS-Testimony | 2009-07-01T04:00:00Z | 2009 | 7 | 2009-07-01T04:00:00Z | 2013-07-27T22:48:13Z | 0 | 0 | 09000064809e630d | ||
| FDA-2009-N-0247-0059 | FDA | None FDA-2009-N-0247 | Genetic Alliance - "Transforming Health Through Genetics Promoting an Environment of Openness (K.Zonno)" [Public Meeting FDA Transparency Task Force, June 24, 2009] - Testimony | Other | TS-Testimony | 2009-07-01T04:00:00Z | 2009 | 7 | 2009-06-03T04:00:00Z | 2009-06-04T03:59:59Z | 2013-07-27T22:48:11Z | 0 | 0 | 09000064809e5b0d | |
| FDA-2009-N-0247-0051 | FDA | None FDA-2009-N-0247 | Microsoft® - "Enabling Transparent Goverance With Gov 2.0 (C.Brubaker)" [Public Meeting FDA Transparency Task Force, June 24, 2009] - Testimony | Other | TS-Testimony | 2009-07-01T04:00:00Z | 2009 | 7 | 2009-06-03T04:00:00Z | 2009-06-04T03:59:59Z | 2013-07-27T22:48:10Z | 0 | 0 | 09000064809e563e | |
| FDA-2009-N-0247-0064 | FDA | None FDA-2009-N-0247 | The Senior Citizens League "Statement of S.Benton" [Public Meeting FDA Transparency Task Force, June 24, 2009] - Testimony | Other | TS-Testimony | 2009-07-01T04:00:00Z | 2009 | 7 | 2009-07-01T04:00:00Z | 2013-08-11T04:34:06Z | 0 | 0 | 09000064809e5b20 | ||
| FDA-2009-N-0247-0060 | FDA | None FDA-2009-N-0247 | Medical Device Manufacturers Association (MDMA) - "Recommendations to Promote Predictability and Transparency (M.Leahy)" - [Public Meeting FDA Transparency Task Force, June 24, 2009] - Testimony | Other | TS-Testimony | 2009-07-01T04:00:00Z | 2009 | 7 | 2009-06-03T04:00:00Z | 2009-06-04T03:59:59Z | 2013-07-27T22:48:11Z | 0 | 0 | 09000064809e5b11 | |
| FDA-2009-N-0247-0067 | FDA | None FDA-2009-N-0247 | The Tatia Oden French Memorial Foundation - " Recommendations to the Transparency Task Force (K.Oden)" - [Public Meeting FDA Transparency Task Force, June 24, 2009] - Testimony | Other | TS-Testimony | 2009-07-01T04:00:00Z | 2009 | 7 | 2009-06-03T04:00:00Z | 2009-06-04T03:59:59Z | 2013-07-27T22:48:13Z | 0 | 0 | 09000064809e630b | |
| FDA-2009-N-0247-0058 | FDA | None FDA-2009-N-0247 | Produce Marketing Association - "Comments for Food and Drug Administration Transparency Task Force (K.Means)" [FDA Transparency Task Force, June 24, 2009] - Testimony | Other | TS-Testimony | 2009-07-01T04:00:00Z | 2009 | 7 | 2009-06-03T04:00:00Z | 2009-06-04T03:59:59Z | 2013-07-27T22:48:10Z | 0 | 0 | 09000064809e566b | |
| FDA-2009-N-0247-0052 | FDA | None FDA-2009-N-0247 | Advanced Medical Technology Association (AdvaMed) - "FDA’s Public Meeting on Transparency (J.Trunzo)" - [Public Meeting FDA Transparency Task Force, June 24, 2009] - Testimony | Other | TS-Testimony | 2009-07-01T04:00:00Z | 2009 | 7 | 2009-06-03T04:00:00Z | 2009-06-04T03:59:59Z | 2013-07-27T22:48:10Z | 0 | 0 | 09000064809e5620 | |
| FDA-2009-N-0247-0057 | FDA | None FDA-2009-N-0247 | Compliance Media Inc. - "FDA: A History: Transparency Taskforce (G.Meyer)" - [Public Meeting FDA Transparency Task Force, June 24, 2009] - Testimony | Other | TS-Testimony | 2009-07-01T04:00:00Z | 2009 | 7 | 2009-06-03T04:00:00Z | 2009-06-04T03:59:59Z | 2013-08-11T03:02:48Z | 0 | 0 | 09000064809e5669 | |
| FDA-2009-N-0247-0055 | FDA | None FDA-2009-N-0247 | Center for Science in the Public Interest - "FDA Transparency Task Force: Recommendations from CSPI (S.Klein)" - [Public Meeting FDA Transparency Task Force, June 24, 2009] - Testimony | Other | TS-Testimony | 2009-07-01T04:00:00Z | 2009 | 7 | 2009-06-03T04:00:00Z | 2009-06-04T03:59:59Z | 2013-07-27T22:48:11Z | 0 | 0 | 09000064809e5a5c | |
| FDA-2009-N-0247-0062 | FDA | None FDA-2009-N-0247 | Physicians Committee for Responsible Medicine (PCRM) "Lessons from Bisphenol A (J.Francer/N.Beck)" - [Public meeting FDA Transparency Task Force, June 24, 2009] - Testimony | Other | TS-Testimony | 2009-07-01T04:00:00Z | 2009 | 7 | 2009-07-01T04:00:00Z | 2013-07-27T22:48:11Z | 0 | 0 | 09000064809e5b19 | ||
| FDA-2009-N-0247-0063 | FDA | None FDA-2009-N-0247 | Pew Prescription Project - "Comments of Pew Prescription Project et al (A.Coukell)" - [FDA Transparency Task Force, June 24, 2009] - Testimony | Other | TS-Testimony | 2009-07-01T04:00:00Z | 2009 | 7 | 2009-07-01T04:00:00Z | 2013-08-11T03:02:48Z | 0 | 0 | 09000064809e5b1e | ||
| FDA-2009-N-0247-0056 | FDA | None FDA-2009-N-0247 | See FDA-2009-N-0247-0094 | Supporting & Related Material | 2009-07-01T00:00:00Z | 2009 | 7 | 2009-08-05T23:30:28Z | 0 | 1 | 09000064809e5664 | ||||
| FDA-2009-N-0247-0001 | FDA | None FDA-2009-N-0247 | Food and Drug Administration Transparency Task Force; Public Meeting | Notice | NM-Notice of Meeting | 2009-06-03T04:00:00Z | 2009 | 6 | 2009-06-03T04:00:00Z | 2009-08-08T03:59:59Z | 2009-07-01T16:59:01Z | E9-12902 | 0 | 0 | 09000064809c3c29 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;